ALXN News 149.80 Alexion Pharmaceuticals (ALXN)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 18, 2014 at 2:58 AM

Alexion Pharmaceuticals (ALXN) 149.80 $ALXN

How Are Orphan Drugmakers Faring in the Great Biotech Downturn?
George Budwell, The Motley Fool - Motley Fool - Thu Apr 17, 5:30PM CDT
There is little debate that we are now in the throes of a general market correction. And because health-care and biotech stocks were the best performers over the past few years, they are being hit particularly hard in this downturn. That said, we...

Emergent BioSolutions Gains on Trial News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 4:10PM CDT
Emergent BioSolutions is looking to expand BioThrax's label.

Alexion Announces the Appointment of John T. Mollen to Its Board of Directors
Business Wire - Thu Apr 17, 3:15PM CDT
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the appointment of John "Jack" T. Mollen to the Company's Board of Directors, effective immediately. The Company also announced that Joseph A. Madri, Ph.D., M.D. and Larry L. Mathis, will retire at the conclusion of the current term on May 5, 2014, after 22 years and 10 years of service to the Company, respectively.

Transition Therapeutics (TTHI) Jumps: Stock Up 11.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:51AM CDT
Transition Therapeutics Inc. was a big mover last session, as its shares rose nearly 12% on the day.

What Falling Estimates & Price Mean for Discovery Laboratories (DSCO) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 7:33AM CDT
A stock that investors may want to consider dropping is Discovery Laboratories Inc. (DSCO)

Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 2.50% Rise
Comtex SmarTrend(R) - Wed Apr 16, 5:38PM CDT
Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $145.24 to a high of $150.79. Yesterday, the shares gained 2.5%, which took the trading range above the 3-day high of $147.50 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 16, 9:07AM CDT
The selloff in the biotech sector continued with overall sentiment remaining bearish.

Good News for BioMarin - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 6:05PM CDT
The FDA has extended Kuvan's marketing exclusivity period.

FDA Nod for Merck's Grastek - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 4:11PM CDT
Merck announced that the FDA has approved Grastek, a timothy grass pollen allergen extract.

Facebook, Walgreen Climb Monday On International News
at Investor's Business Daily - Mon Apr 14, 4:32PM CDT
Overseas news helped boost two U.S. industry leaders Monday, with Walgreen (WAG) gaining 3% and Facebook (FB) up 2%. Facebook is reportedly within weeks of potential permission from Ireland's central bank that would authorize it to add financial...

Pipeline Progress at Coronado Biosciences - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 4:20PM CDT
Coronado Biosciences commenced a study evaluating TSO for the treatment of pediatric patients with autism spectrum disorder.

Positive Results on Intercept Pharma's OCA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 3:30PM CDT
Intercept Pharma announced positive additional data from the phase III study on obeticholic acid.

Gilead Bucks Biotech Trend Thanks to Sovaldi News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 10:30AM CDT
Gilead gained on news related to Sovaldi.

Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences
PR Newswire - Mon Apr 14, 8:00AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89% to 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the 10 sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has lost 4.46% in the last one month. Investor-Edge has initiated coverage on the following equities: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Incyte Corp. Ltd (NASDAQ: INCY), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) and Aastrom Biosciences Inc. (NASDAQ: ASTM). Free technical research on ALXN, INCY, MACK and ASTM can be downloaded upon signing up at:

Acquisitions, Director Appointments, Collaborations, New Product Launches, and Earnings Guidance Revisions - Analyst Notes on Questcor, Regeneron, Lilly, Medtronic and Alexion
PR Newswire - Mon Apr 14, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), Regeneron Pharmaceuticals Inc. (NASDAQ: REGN), Eli Lilly and Co. (NYSE: LLY), Medtronic Inc. (NYSE: MDT) and Alexion Pharmaceuticals Inc. (NASDAQ: ALXN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1084-100free.

Researchers to Present New Data on Asfotase Alfa in Infants and Juveniles with Hypophosphatasia at the Joint Meeting of the Pediatric Academic Societies and the Asian Society for Pediatric Research
Business Wire - Fri Apr 11, 5:11PM CDT
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that researchers are scheduled to present new data from the extension phase of two clinical studies examining the long-term efficacy and safety of asfotase alfa in infants and juveniles with hypophosphatasia (HPP) at the joint meeting of the Pediatric Academic Societies (PAS) and the Asian Society for Pediatric Research, which takes place May 3-6, 2014 in Vancouver, B.C., Canada. The meeting will also feature the presentation of results from a retrospective natural history study of patients with perinatal and infantile HPP.

Update on BioLineRx's BL-8040 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 5:10PM CDT
BioLineRx announced that Prof. Arnon Nagler was given the final regulatory approval to evaluate BL-8040 in a phase I/II study for the treatment of CML.

Encouraging Results on Gilead's Sovaldi - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:15PM CDT
Gilead announced encouraging results from two phase II studies and a compassionate access study on Sovaldi.

Positive Data on Biogen/Sobi's Eloctate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 10:40AM CDT
Biogen/Sobi reported positive top-line data on their hemophilia A candidate, Eloctate from a phase III pediatric study (Kids A-LONG).

Rite Aid (RAD) Jumps: Stock Up 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 8:39AM CDT
Rite Aid Corporation was a big mover last session, as its shares rose over 8% on the day.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Wulcea Pioneers Safety in Smart Heated Apparel

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Rural AI Skills Gap Uncovered: Challenges and Solutions

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Fashion and Philanthropy Unite at UBCF Kick-off Party

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Fluence Energy Faces Class Action: Investors Beware

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Yangtze River Culture Festival Spotlights Integration, Tradition

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...